Charmacy Pharmaceutical Co. Ltd. held its annual general meeting on 22 May 2025. During the meeting, several proposals were considered and approved. These included amendments to the rules of procedures for Board meetings, authorizing any Director to modify the wordings of such amendments as appropriate, and executing necessary documents related to these amendments. All resolutions proposed were duly passed by the Shareholders.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.